Despite TGF-β1-ECM-FAK being recognized as key proteins in IPF and FAK inhibitors being used in several IPF animal model studies [14, 15], no research has focused on a FAK-based gene signature for IPF prognosis. The gene discussed is PTK2; the disease is idiopathic interstitial pneumonia.